Oyanagi J, Koh Y, Sato K, Teraoka S, et al. Bloodborne Cytokines for Predicting Clinical Benefits and Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated With Anti-Programmed Cell Death 1 Inhibitors. Clin Lung Cancer 2021 Apr 27. pii: S1525-7304(21)00091.
PMID: 34049821